04:04 PM EDT, 09/24/2024 (MT Newswires) -- Health care stocks were mixed late Tuesday afternoon, with the NYSE Health Care Index up fractionally and the Health Care Select Sector SPDR Fund (XLV) shedding 0.3%.

The iShares Biotechnology ETF (IBB) fell 0.3%.

In corporate news, Capricor Therapeutics ( CAPR ) shares soared 52%. The company said Tuesday it intends to start filing a biologics license application in October seeking full approval of deramiocel to treat Duchenne muscular dystrophy cardiomyopathy.

Seelos Therapeutics ( SEEL ) said Tuesday its SLS-002 was selected for inclusion in the US Department of Defense's Military and Veterans Adaptive Platform Clinical Trial to evaluate its potential to treat post-traumatic stress disorder. Its shares surged 54%.

Banks and private credit lenders are lining up more than 10 billion euros ($11.1 billion) of debt to back a buyout of Sanofi's ( SNY ) consumer health unit, Bloomberg reported. The news outlet also reported that the French drugmaker has received two binding bids for the unit, valuing it at 15 billion euros. Sanofi ( SNY ) shares added 0.3%.

Wave Life Sciences ( WVE ) shares jumped past 53% after the company reported "positive" interim data from a phase 2 trial of WVE-N531 to treat boys with Duchenne muscular dystrophy.